US 9126956
Neprilysin inhibitors
granted A61KA61K31/415A61K31/4192
Quick answer
US patent 9126956 (Neprilysin inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 43
- CPC classes
- A61K, A61K31/415, A61K31/4192, A61K31/42, A61K31/421